Transaction #12909 · Form 4 · 0001104659-25-116424
OCULAR THERAPEUTIX, INC · Gift received · Common Stock
OCULAR THERAPEUTIX, INC · Transacted November 26, 2025 · Filed November 26, 2025
What does this filing report?
An SEC Form 4 filing for OCULAR THERAPEUTIX, INC records a gift received involving Common Stock on November 26, 2025. The reported quantity was 49,754. The filing date is November 26, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- OCULAR THERAPEUTIX, INC
- Company CIK
- 0001393434
- Security type
- Non-derivative
- Acquisition type
- Gift received · Code G
- Quantity acquired
- 49,754
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 300,115
- Ownership description
- By Pravin Dugel 2024 Irrevocable Trust
- SEC acceptance time
- Nov 26, 2025, 4:02 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Dugel Pravin ↗
See Remarks · Director
CIK 0001700917
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person.
- F2
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.74 to $12.34, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- F3
- On November 26, 2025, the reporting person's spouse transferred 49,754 shares to the Pravin Dugel 2024 Irrevocable Trust (the "Trust") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust.
Remarks
Executive Chairman, President and CEO
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.